[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1986

Enucleation vs Cobalt Plaque Radiotherapy for Malignant Melanomas of the Choroid and Ciliary Body

Author Affiliations

From the Oncology Service, Department of Ophthalmology, Wills Eye Hospital, Jefferson Medical College, Thomas Jefferson University, Philadelphia (Drs Augsburger, Sardi, and Shields), the Departments of Ophthalmology (Dr Gamel) and Community Health (Dr Greenberg), University of Louisville School of Medicine, and the Department of Radiation Oncology, Hahnemann University College of Medicine, Philadelphia (Dr Brady).

Arch Ophthalmol. 1986;104(5):655-661. doi:10.1001/archopht.1986.01050170045019
Abstract

• Clinical risk factors were assessed prospectively in a nonrandomized concurrent observational study of 237 patients with posterior uveal malignant melanoma. One hundred forty of these patients were treated with enucleation, and 97 underwent cobalt plaque radiotherapy. Tumor size and location of the anterior tumor margin proved to be the most significant clinical risk factors for death from metastatic melanoma. When Cox proportional hazards modeling was used to adjust for recognized intergroup differences in risk factors, the effect of therapy (enucleation vs cobalt plaque radiotherapy) on survival time was not statistically significant. We discuss the implications of this study for a randomized clinical trial of enucleation vs cobalt plaque therapy or comparable forms of irradiation.

×